Work

Upadacitinib in refractory cutaneous pseudolymphoma: A case report

Year: 2025

Type: article

Abstract: Cutaneous pseudolymphoma is a benign condition characterized by a reactive B-cell, T-cell or mixed lymphoproliferative process. Different causative agents (e.g. injected substances, tattoo, drugs and insect bites) have been described, but in many cases no cause can be identified; hence, the term idiopathic cutaneous pseudolymphoma. There are no specific guidelines for the treatment of cutaneous pseudolymphoma, and sometimes a few cases are refractory to conventional treatments. We describe a case of a 41-year-old African woman with refractory facial IgG4 pseudolymphoma successfully treated with upadacitinib.

Source: SAGE Open Medical Case Reports

DOI: 10.1177/2050313x251350370

Authors: Elisabetta Danese, Tea Curic, Francesco Bellinato, Chiara Colato, Paolo Gisondi, Giampiero Girolomoni

Institution: University of Verona

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,000